Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 50 out of 100. Down syndrome and Alzheimer's

Topic: Brain proteins, microglia and lab models

Plain-language summary

Adult individuals with Down syndrome (DS) develop Alzheimer disease (AD). Whether there is a difference between AD in DS and AD regarding the structure of amyloid-β (Aβ) and tau filaments is unknown. Here we report the structure of Aβ and tau filaments from two DS brains. We found two Aβ 40 filaments (types IIIa and IIIb) that differ from those previously reported in sporadic AD and two types of Aβ 42 filaments (I and II) identical to those found in sporadic and familial AD. Tau filaments (paired helical filaments and straight filaments) were identical to those in AD, supporting the notion of a common mechanism through which amyloids trigger aggregation of tau. This knowledge is important for understanding AD in DS and assessing whether adults with DS could be included in AD clinical trials.

What this study adds

Evidence grade: Low

Using cryo-electron microscopy on two Down syndrome brains, this study found two amyloid beta 40 filament types that differ from sporadic Alzheimer disease and amyloid beta 42 and tau filaments identical to those in Alzheimer disease. It describes protein structure only and does not test any treatment, though the authors note it may help assess whether adults with Down syndrome could join Alzheimer clinical trials.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Fernandez, A., Hoq, M. R., Hallinan, G. I., Li, D., Bharath, SR., Vago, F. S., et al. (2024). Cryo-EM structures of amyloid-β and tau filaments in Down syndrome. Nature structural & molecular biology. https://doi.org/10.1038/s41594-024-01252-3

Vancouver

Fernandez A, Hoq MR, Hallinan GI, Li D, Bharath SR, Vago FS, et al. Cryo-EM structures of amyloid-β and tau filaments in Down syndrome. Nature structural & molecular biology. 2024. doi:10.1038/s41594-024-01252-3. PMID: 38553642.

BibTeX

@article{fernandez2024-38553642,
  author  = {Fernandez, A. and Hoq, M. R. and Hallinan, G. I. and Li, D. and Bharath, SR. and Vago, F. S. and Zhang, X. and Ozcan, K. A. and others},
  title   = {{Cryo-EM structures of amyloid-β and tau filaments in Down syndrome}},
  journal = {Nature structural \& molecular biology},
  year    = {2024},
  doi     = {10.1038/s41594-024-01252-3},
  pmid    = {38553642},
  url     = {https://doi.org/10.1038/s41594-024-01252-3}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

Using cryo-electron microscopy on two Down syndrome brains, this study found two amyloid beta 40 filament types that differ from sporadic Alzheimer disease and amyloid beta 42 and tau filaments identical to those in Alzheimer disease. It describes protein structure only and does not test any treatment, though the authors note it may help assess whether adults with Down syndrome could join Alzheimer clinical trials.

Study details

How this study scored 50/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 1 of 6; Still being cited 3 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 50 of 100.50 of 100 points earned50 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Nature structural & molecular biology)
Journal's citation record 3 / 4 Nature Structural & Molecular Biology: journal h-index 322 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 50 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 12.5 citations a year over 4 year(s) since 2024
Impact for its field and year 4 / 6 Cited 12.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 3 / 4 Cited 50 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Rubén Vidal: h-index 50 (OpenAlex, whole career)
Institution's track record 1 / 3 Purdue University West Lafayette: institution h-index 983 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 38553642)
Free to read 2 / 2 Free to read
Total 50 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Down syndrome and Alzheimer's from nearby years

Also tagged “down”

527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →